Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
12 participants
INTERVENTIONAL
2024-08-01
2026-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dyadic Sleep Study
NCT06569693
Feasibility and Acceptability Study of My Sleep Our Sleep (MSOS) Program
NCT04712604
Sleep Treatment Education Program for Cancer Survivors: STEP-Together
NCT06736548
Sleep Management in Cancer Survivors
NCT00935376
Insomnia Interventions in Cancer Survivors
NCT02783079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phase 2 BBTI Intervention Group
Participants (patient-sleep-partner caregiver dyads) in this group will receive the Brief Behavioral Treatment for Insomnia (BBTI). Total participation is up to 4 weeks.
Brief Behavioral Treatment for Insomnia (BBTI)
BBTI is brief patient-focused intervention for patient-sleep-partner caregiver dyads, aimed at altering participants' sleep behaviors to improve sleep. BBTI utilizes behavioral education in sleep restriction and stimulus control. For sleep restriction, participants will be instructed to limit the time spent in bed, which serves to increase sleep efficiency. For stimulus control, participants will be instructed to go to bed only when feeling sleepy and reserve the bed for sleep and intimacy.
BBTI will be delivered over four weeks, in weekly one-hour sessions, one session per week.
Phase 2 MSOS Intervention Group
Participants (patient-sleep-partner caregiver dyads) in this group will receive the My Sleep Our Sleep (MSOS) intervention. Total participation is up to 4 weeks.
My Sleep Our Sleep (MSOS)
MSOS is a sleep intervention developed by the investigator aimed at improving sleep health for patient-sleep-partner caregiver dyads using behavioral education in sleep behaviors, sleep cognition and sleep in relationship.
MSOS will be delivered over four weeks, in weekly one-hour sessions, one session per week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brief Behavioral Treatment for Insomnia (BBTI)
BBTI is brief patient-focused intervention for patient-sleep-partner caregiver dyads, aimed at altering participants' sleep behaviors to improve sleep. BBTI utilizes behavioral education in sleep restriction and stimulus control. For sleep restriction, participants will be instructed to limit the time spent in bed, which serves to increase sleep efficiency. For stimulus control, participants will be instructed to go to bed only when feeling sleepy and reserve the bed for sleep and intimacy.
BBTI will be delivered over four weeks, in weekly one-hour sessions, one session per week.
My Sleep Our Sleep (MSOS)
MSOS is a sleep intervention developed by the investigator aimed at improving sleep health for patient-sleep-partner caregiver dyads using behavioral education in sleep behaviors, sleep cognition and sleep in relationship.
MSOS will be delivered over four weeks, in weekly one-hour sessions, one session per week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* newly diagnosed with stage I to IV of a solid tumor
* diagnosis in the past seven years at the time of enrollment
* having a consistent sleep partner.
* The eligibility criterion for caregivers is
* a sleep partner of the patient.
* Additional eligibility criteria for both patients and caregivers are
* Pittsburgh Sleep Quality Index (PSQI) ≥ 5,
* willing to change sub-optimal sleep habits,
* 18 years or older,
* able to speak/listen English at the 8th grade level for intervention sessions,
* able to read English or Spanish at the 8th grade for self-reported questionnaires, reside in Brevard County, Florida (FL),
* only for participants of Aim 2, \> 4 weeks after surgery, if any, prior to enrollment, and no surgery planned in the next 5 weeks during the study period because surgery affects sleep.
Exclusion Criteria
* active suicidality, or substance or alcohol dependency in the past year;
* currently have narcolepsy, restless leg syndrome, or untreated sleep apnea that is screened using the Sleep Health Screen;
* both patients and caregivers have an extreme chronotype, or do shift work to have no overlap in sleep schedule between them; and
* plan trans-meridian travel during the period of data collection blocks; and
* having hearing or visual impairment, dementia, or cognitive dysfunction.
* Adults unable to consent, individuals who are not yet adults, pregnant women, or prisoners will be excluded.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Community Foundation for Brevard
UNKNOWN
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Youngmee Kim
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Youngmee Kim, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami
Coral Gables, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-06704
Identifier Type: REGISTRY
Identifier Source: secondary_id
20231290
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.